CLINICAL AND ANALYTICAL DIFFERENCES BETWEEN CALR TYPE-1 AND CALR TYPE-2 MUTATION IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS: A SINGLE CENTER STUDY

被引：0

作者：

Sobas, M. ^{[1
]}

Olejniczak, M. ^{[1
]}

Andrasiak, I. ^{[2
]}

Kruszewski, M. ^{[3
]}

Jazwiec, B. ^{[1
]}

Rybka, J. ^{[1
]}

Wrobel, T. ^{[1
]}

Kuliczkowski, K. ^{[1
]}

机构：

[1] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Wroclaw, Poland

[2] WroMed Res Ctr, Wroclaw, Poland

[3] Wroclaw Med Univ, Wroclaw, Poland

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PB2032

引用

页码：809 / 809

页数：1

共 50 条

[21] Comparison of CALR Mutation Testing on Peripheral Blood To Paraffin Embedded Bone Marrow Tissue in Nonmutated JAK2 Primary Myelofibrosis and Essential Thrombocythemia
Menke, Joshua
Chehab, Farid
Prakash, Sonam
LABORATORY INVESTIGATION, 2015, 95 : 363A - 363A
[22] CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms Primary Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera, and Myeloproliferative Neoplasm, Unclassifiable
Kim, Seon Young
Im, Kyongok
Park, Si Nae
Kwon, Jiseok
Kim, Jung-Ah
Lee, Dong Soon
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (05) : 635 - 644
[23] Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
Mónica Mejía-Ochoa
Paola Andrea Acevedo Toro
Jaiberth Antonio Cardona-Arias
BMC Cancer, 19
[24] CALR MUTATION TYPE INFLUENCES THE RISK OF THROMBOSIS IN ESSENTIAL THROMBOCYTEMIA ACCORDING TO A COOPERATIVE STUDY BETWEEN TWO SPANISH CENTERS
Abuin Blanco, A.
Saez Salinas, A.
Bao Perez, L.
Gonzalez Martin, J. M.
Lopez Jaime, F. J.
Torres Minana, L.
Mosquera Orgeira, A.
Bilbao Sieyro, C.
Quinteiro Garcia, C.
Gonzalez Martinez, T.
Florido Ortega, Y.
Ulibarrena Redondo, C.
Santana Santana, G.
Rabunal Martinez, M. J.
Diaz Varela, N.
Bendana Lopez, A.
Alonso Vence, N.
Gonzalez Perez, M. S.
Bello Lopez, J. L.
Perez Encinas, M. M.
Gomez Casares, M. T.
HAEMATOLOGICA, 2017, 102 : 545 - 545
[25] IMPACT OF JAK2 AND CALR MUTATIONS ON THE DISEASE FEATURES AND OUTCOME AMONG PATIENTS WITH PRIMARY MYELOFIBROSIS OR ESSENTIAL THROMBOCYTHEMIA TREATED WITH STANDARD OF CARE (INCLUDING RUXOLITINIB)
Hupfer, V.
Wehrle, J.
Niemoeller, C.
Bleul, S.
Kirchner, C.
Pfeifer, D.
Haferlach, T.
Werner, M.
Duyster, J.
von Bubnoff, N.
Waller, C.
Pahl, H. L.
Becker, H.
HAEMATOLOGICA, 2016, 101 : 562 - 562
[26] CLINICAL IMPORTANCE OF AGE AT ONSET IN TYPE-1 AND TYPE-2 PRIMARY ALCOHOLICS
IRWIN, M
SCHUCKIT, M
SMITH, TL
ARCHIVES OF GENERAL PSYCHIATRY, 1990, 47 (04) : 320 - 324
[27] Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000-2018
Mejia-Ochoa, Monica
Acevedo Toro, Paola Andrea
Antonio Cardona-Arias, Jaiberth
BMC CANCER, 2019, 19 (1)
[28] On the Fundamental Differences Between Interval Type-2 and Type-1 Fuzzy Logic Controllers
Wu, Dongrui
IEEE TRANSACTIONS ON FUZZY SYSTEMS, 2012, 20 (05) : 832 - 848
[29] Type 1/like Calr Mutation in Momelotinib-Treated Patients with Myelofibrosis Is the Most Prominent Predictor of Drug Survival and Longevity without Transplant
Tefferi, Ayalew
Pardanani, Animesh D.
Begna, Kebede
Al-Kali, Aref
Hogan, William J.
Litzow, Mark R.
Gangat, Naseema
BLOOD, 2023, 142
[30] Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients
Qiao, Chun
Sun, Chao
Ouyang, Yuan
Wang, Ju-Juan
Qian, Si-Xuan
Li, Jian-Yong
Zhang, Su-Jiang
HAEMATOLOGICA, 2014, 99 (10) : E182 - E184

← 1 2 3 4 5 →